As the hemp, cannabis, and CBD space comes roaring back in recent months, representing what appears to be a long-term cyclical bottom following the 2018-2020 sector bear market, investors will be tasked with the mission of scoping new leaders as they emerge from the rubble. In the current health crisis, flexibility and innovation will be key advantages. One company making an increasingly interesting case right now is CBD Life Sciences Inc. (OTCMKTS:CBDL), which launched a CBD+CBG hand sanitizer product in mid-April to much fanfare.

CBDL is an overarching structure that holds a primary operating subsidiary called LBC Bioscience Inc., a CBD-based products company that has developed a full line of cannabidiol based organic products, including CBD hemp drops, pain relief creams, anxiety and sleep supplements, brain booster coffee, weight loss coffee, an anti-aging skin line, and a full line of CBD infused supplements for pets.